Restricting α-synuclein transport into mitochondria by inhibition of α-synuclein-VDAC complexation as a potential therapeutic target for Parkinson's disease treatment
通过抑制 α-突触核蛋白-VDAC 复合来限制 α-突触核蛋白转运到线粒体,作为帕金森病治疗的潜在治疗靶点
期刊:Cellular and Molecular Life Sciences
影响因子:6.2
doi:10.1007/s00018-022-04389-w
Megha Rajendran, María Queralt-Martín, Philip A Gurnev #, William M Rosencrans, Amandine Rovini, Daniel Jacobs, Kaitlin Abrantes, David P Hoogerheide, Sergey M Bezrukov, Tatiana K Rostovtseva